Archon Biosciences
PrivateLast Round
Seed
Oct 30, 2024
Total Funding Raised
$27M
Company Overview
Archon Biosciences operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Seed round in October 2024.
Archon Biosciences is a biotechnology company that develops computationally designed Antibody Cages (AbCs) to unlock therapeutic targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Archon Biosciences Comparables
Compare Archon Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Accipiter Biosciences | 85% | |
| Synolo Therapeutics | 80% | |
| Cellemedy | 78% |
For institutional investors. Book with your work email.
Archon Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Archon Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Duke University Management Company | Seed |
| Cornucopian Capital | Seed |
| United States Department of Defense | Grant |
| NIH RADx | Grant |
| WRF Capital | Seed |
| Pack Ventures | Seed |
| Washington Research Foundation Capital | Seed, Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2024
Developing unique protein structures called Antibody Cages (AbCs).
For institutional investors. Book with your work email.
Archon Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Archon Biosciences's valuation, stock price, and market status.
Is Archon Biosciences a public or private company?
Archon Biosciences is a private company.
What is the current stock price of Archon Biosciences?
Archon Biosciences is a private company, so its shares have no public market price. Caplight tracks Archon Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Archon Biosciences worth (valuation)?
Valuation information for Archon Biosciences is not publicly available.
Can I buy Archon Biosciences stock?
Archon Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Archon Biosciences's last funding round?
Archon Biosciences's most recent funding round was Seed on October 30, 2024.
Who are the main investors in Archon Biosciences?
Key investors in Archon Biosciences include Madrona Venture Group.
Will Archon Biosciences IPO soon?
No public IPO plans have been announced for Archon Biosciences.
How can I track Archon Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Archon Biosciences's shares on secondary markets.